subject: CHEBI:23965

subject_name: estradiol

object_name: bacterial vaginosis


subject: CHEBI:23965

object_name: HIV-1 infection

tested_intervention: yes


subject: UMLS:C0561938

subject_name: Potassium supplementation (product)

object_name: Hydration status

tested_intervention: unsure


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: gastric neoplasm


subject: UMLS:C2828372


subject: CHEBI:79369

subject_name: Elesclomol

object_name: melanoma


subject: UMLS:C1541326


subject: CHEBI:7494

subject_name: Nefazodone

object_name: cocaine abuse


subject: CHEBI:32010

subject_name: Piracetam

object_name: tardive dyskinesia


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: complications of organ transplant stem cells


subject: PUBCHEM.COMPOUND:1805

object_name: Isolated thrombocytopenia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:28939

subject_name: Acetylcysteine


subject: UMLS:C5234969

subject_name: Cam

object_name: T-Cell Lymphoma


subject: UMLS:C0678112

subject_name: CAM brand of Ephedrine Hydrochloride


subject: CHEBI:3732

subject_name: Clarithromycin


subject: UniProtKB:P62158

subject_name: Calmodulin 1


subject: UniProtKB:P0DP23

subject_name: CALM1_HUMAN Calmodulin-1 (sprot)


subject: UMLS:C0007578

subject_name: Cell Adhesion Molecules


subject: UniProtKB:P0DP29

subject_name: CALM1_RAT Calmodulin-1 (sprot)


subject: PR:000049739

subject_name: calmodulin (rat)


subject: UniProtKB:P62157

subject_name: CALM_BOVIN Calmodulin (sprot)


subject: PR:000004978

subject_name: calmodulin


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Hypernatremia


subject: UMLS:C0445115

object_name: Hypernatremia, CTCAE


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Fractured mandible


subject: CHEBI:41879

object_name: Facial edema


subject: CHEBI:41879

object_name: Edema Face, CTCAE


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:50858

subject_name: corticosteroid


subject: CHEBI:50858


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: MESH:D000305


subject: UMLS:C3536709

subject_name: Corticosteroid [EPC]


subject: UMLS:C3536709


subject: UMLS:C3536709


subject: UMLS:C1271481

subject_name: Recombinant human granulocyte colony stimulating factor

object_name: neonatal sepsis


subject: UMLS:C1271481

object_name: Bacterial sepsis of newborn


subject: UMLS:C0376562

subject_name: Recombinant Granulocyte Colony Stimulating Factor


subject: UMLS:C0376562


subject: CHEBI:125628

subject_name: Alisertib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:16646

subject_name: carbohydrate

object_name: Surgical procedure finding


subject: CHEBI:16646

object_name: Inflammation


subject: CHEBI:231679

subject_name: ipilimumab

object_name: lip carcinoma in situ


subject: CHEBI:231679

object_name: Neoplasm of uncertain or unknown behavior of lip, oral cavity and pharynx


subject: CHEBI:231679

object_name: Neoplasm of uncertain or unknown behavior of larynx


subject: CHEBI:231679

object_name: laryngeal disorder


subject: CHEBI:231679

object_name: larynx carcinoma in situ


subject: CHEBI:231679

object_name: benign laryngeal neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:8356

subject_name: Pramipexole

object_name: chronic pain (diagnosis)


subject: CHEBI:8356

object_name: Chronic pain


subject: UMLS:C5417830

subject_name: Rilunermin Alfa

object_name: Malignant pleural effusion


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: pleomorphic adenoma


subject: UNII:618SLL9VBS

subject_name: Omiganan

object_name: Papulopustular Rosacea


subject: UMLS:C4550028


subject: CHEBI:6775

subject_name: Mesalazine

object_name: lymphocytic colitis


subject: UNII:UQ6CV583Q3

subject_name: FLUCICLATIDE

object_name: smoldering plasma cell myeloma


subject: UNII:UQ6CV583Q3

object_name: plasma cell myeloma


subject: UNII:UQ6CV583Q3

object_name: monoclonal gammopathy of uncertain significance


subject: UMLS:C4045542

subject_name: Fluciclatide


subject: UMLS:C4045542


subject: UMLS:C4045542


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB

object_name: urothelial carcinoma


subject: PUBCHEM.COMPOUND:90199447

object_name: transitional cell carcinoma


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: chronic post-thoracotomy pain


subject: CHEBI:64356

subject_name: Pregabalin


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Fatty Liver


subject: UMLS:C0169964

subject_name: somatropin


subject: UNII:N824AOU5XV

subject_name: Pegvisomant


subject: UNII:9013DUQ28K

subject_name: Anakinra

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:32016

subject_name: Pirfenidone

object_name: chronic hepatitis C virus infection


subject: CHEBI:47657

subject_name: Roflumilast

object_name: bronchiectasis


subject: CHEBI:47657

object_name: COPD exacerbation


subject: CHEBI:47657

object_name: Hypoventilation


subject: UMLS:C5575682

subject_name: Kefir antigen

object_name: Fatigue, CTCAE 5.0


subject: UMLS:C5575682

object_name: Fatigue


subject: CHEBI:135207

subject_name: Clofedanol

object_name: HIV infection


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: PR:000004321

subject_name: arylsulfatase A


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:8863

subject_name: Riluzole

object_name: Cervical myelopathy


subject: DRUGBANK:DB17575

subject_name: Utidelone

object_name: breast neoplasm


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: hereditary breast ovarian cancer syndrome


subject: PUBCHEM.COMPOUND:139331475

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:139331475

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:139331475

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:139331475

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:139331475

object_name: malignant epithelial tumor of ovary


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:51141

subject_name: Alfuzosin

object_name: lower urinary tract symptom


subject: UMLS:C4722546

object_name: cervical cancer


subject: UMLS:C4722546

object_name: cervical carcinoma


subject: CHEBI:6904

subject_name: Metoprolol

object_name: sleep apnea


subject: CHEBI:4875

subject_name: Etanercept

object_name: vasculitis


subject: CHEBI:4875

object_name: Vasculitis, CTCAE


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PR:000001959


subject: PUBCHEM.COMPOUND:5289549

object_name: Postmenopausal osteoporosis, multiple sites


subject: UMLS:C0700789

subject_name: MSIR

object_name: Low back pain


subject: UMLS:C5238987

object_name: esophageal squamous cell carcinoma


subject: GTOPDB:11278

subject_name: bemarituzumab

object_name: Gastroesophageal junction cancer


subject: UNII:RJW23BQ0KW


subject: UMLS:C3896858


subject: PR:000013574

subject_name: sulfhydryl oxidase 1


subject: CHEBI:73024

subject_name: O-acetylcarnitine

object_name: hypertension


subject: CHEBI:73024

object_name: Hypertension, CTCAE


subject: CHEBI:73024

object_name: type 2 diabetes mellitus


subject: CHEBI:57589

subject_name: Acetylcarnitine


subject: CHEBI:57589


subject: CHEBI:57589


subject: CHEBI:135905

subject_name: Terlipressin

object_name: Hemoptysis


subject: CHEBI:6121

subject_name: Ketamine

object_name: trigeminal neuralgia


subject: UNII:JUP57A8EPZ

object_name: Hepatic impairment


subject: DRUGBANK:DB19218

subject_name: Camizestrant


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: atrial fibrillation


subject: UMLS:C0054066

object_name: Atrial Fibrillation by ECG Finding


subject: UMLS:C0054066

object_name: Atrial Fibrillation, CTCAE


subject: UMLS:C0054066

object_name: Deep Venous Thrombosis Related to COVID-19


subject: UMLS:C0054066

object_name: Deep venous thrombosis


subject: UMLS:C0054066

object_name: pulmonary embolism


subject: UMLS:C0521939

subject_name: Selenium supplement

object_name: malnutrition


subject: GTOPDB:9802

object_name: Liver transplant rejection


subject: UMLS:C4548814


subject: CHEBI:30496

subject_name: Sulfur hexafluoride

object_name: rhegmatogenous retinal detachment


subject: PUBCHEM.COMPOUND:5497107

subject_name: Monosialoganglioside GM1

object_name: Ischemic stroke


subject: CHEBI:73110

subject_name: ganglioside GM1(1-)


subject: CHEBI:61048

subject_name: Ganglioside GM1


subject: UMLS:C1440974


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Advanced breast cancer


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Stage IV Nasopharyngeal Carcinoma


subject: CHEBI:72317

object_name: Nasopharyngeal cancer recurrent


subject: CHEBI:72317

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v8


subject: CHEBI:6801

subject_name: Metformin

object_name: mixed anxiety and depressive disorder


subject: CHEBI:49325

subject_name: oral contraceptive


subject: CHEBI:49325

object_name: Polycystic ovary syndrome of bilateral ovaries


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: UMLS:C0009905


subject: CHEBI:65345

subject_name: Sonolisib

object_name: glioblastoma


subject: CHEBI:65345

object_name: Childhood Glioblastoma


subject: CHEBI:65345

object_name: adult glioblastoma


subject: CHEMBL.COMPOUND:CHEMBL4297696

object_name: pneumonia caused by pseudomonas aeruginosa infection


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate

object_name: carpal tunnel syndrome


subject: UMLS:C0699627

subject_name: Depo-Medrone


subject: UNII:39IS23Q1EW

subject_name: Cedazuridine

object_name: melanoma


subject: UMLS:C5390939

subject_name: cedazuridine / decitabine


subject: UNII:L65E7T81M5

subject_name: DULANERMIN

object_name: colorectal cancer


subject: UNII:L65E7T81M5

object_name: colorectal carcinoma


subject: UNII:L65E7T81M5

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1522480

subject_name: AMG 951


subject: UMLS:C1522480


subject: UMLS:C1522480


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: coronary artery disorder


subject: CHEBI:63611

object_name: coronary atherosclerosis


subject: CHEBI:76842

object_name: Insulin resistance


subject: CHEBI:28001

subject_name: Vancomycin


subject: DRUGBANK:DB10640

subject_name: Beet


subject: DRUGBANK:DB10640


subject: DRUGBANK:DB10640


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: graft versus host disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: temporomandibular joint dysfunction syndrome


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:91402

subject_name: linsitinib

object_name: Neck Carcinoma


subject: CHEBI:91402

object_name: head and neck neoplasm


subject: CHEBI:91402

object_name: head and neck cancer


subject: UMLS:C2346449

subject_name: OSI 906


subject: UMLS:C2346449


subject: UMLS:C2346449


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: salivary gland carcinoma


subject: PUBCHEM.COMPOUND:131769963

object_name: salivary gland cancer


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: UMLS:C3854325

subject_name: Janus kinase inhibitor

object_name: psoriasis


subject: CHEBI:189653

subject_name: pelabresib

object_name: adult lymphoma


subject: CHEBI:189653

object_name: lymphoma


subject: CHEBI:189653

object_name: pediatric lymphoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Melanoma recurrent


subject: CHEBI:391960

subject_name: Darifenacin

object_name: Neurogenic detrusor overactivity


subject: UMLS:C0002525

subject_name: Amino Acids, Essential

object_name: chronic kidney disease


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: neoplasm


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: CHEBI:61397

subject_name: Neratinib

object_name: colorectal cancer


subject: CHEBI:61397

object_name: colorectal carcinoma


subject: CHEBI:61397

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:51209

subject_name: Pseudoephedrine

object_name: common cold


subject: CHEBI:51209

object_name: pharyngitis


subject: CHEBI:51209

object_name: Pharyngitis, CTCAE


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: Ischemic stroke


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: osteoarthritis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: concussion


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: pervasive developmental disorder


subject: CHEBI:4696

object_name: autism


subject: CHEBI:145499

subject_name: Donepezil


subject: CHEBI:145499


subject: CHEBI:70839

subject_name: Dasatinib

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:70839

object_name: Adult L2 Acute Lymphoblastic Leukemia


subject: CHEBI:70839

object_name: Adult L1 Acute Lymphoblastic Leukemia


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:233364

subject_name: Bryostatin

object_name: lung cancer


subject: CHEBI:233364

object_name: lung neoplasm


subject: CHEBI:233364

object_name: lung carcinoma


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: CHEBI:88353


subject: UMLS:C2830015

subject_name: INT 747

object_name: Fatty Liver


subject: UMLS:C2830015

object_name: type 2 diabetes mellitus


subject: CHEBI:43602

subject_name: Obeticholic acid


subject: CHEBI:3219

subject_name: Bupropion

object_name: Nicotine Addiction


subject: PUBCHEM.COMPOUND:24840146

subject_name: BUTORPHANOL TARTRATE

object_name: abortion


subject: CHEBI:3242

subject_name: butorphanol


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Clostridium infectious disease


subject: CHEBI:26710

object_name: Dysbiosis


subject: CHEBI:240107

subject_name: Bromfenac

object_name: myopia


subject: CHEBI:6888

object_name: contact dermatitis


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: HIV lipodystrophy


subject: CHEBI:229652

subject_name: Iptacopan

object_name: Myasthenia Gravis, Generalized


subject: UMLS:C0770255

subject_name: carbohydrate supplement

object_name: bariatric surgery candidate


subject: UMLS:C0770255

object_name: diabetic hyperglycaemia


subject: UMLS:C1550146

subject_name: Other - Substance Type

object_name: heart failure


subject: UMLS:C1550146

object_name: Heart Failure, CTCAE


subject: UMLS:C1550146

object_name: dilated cardiomyopathy


subject: UMLS:C1550146

object_name: cardiomyopathy


subject: UMLS:C1550146

object_name: heart disorder


subject: CHEBI:3023

subject_name: Benzbromarone


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Ovarian Steroid Cell Tumor


subject: CHEBI:45863

object_name: ovarian Sertoli-Leydig cell tumor


subject: CHEBI:45863

object_name: Adult Type Ovarian Granulosa Cell Tumor


subject: CHEBI:45863

object_name: ovarian sex cord-stromal tumor


subject: CHEBI:45863

object_name: Ovarian Sex Cord Tumor with Annular Tubules


subject: CHEBI:45863

object_name: ovarian gynandroblastoma


subject: UNII:J2WIV0JMML

subject_name: Loxicodegol

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:54751657

subject_name: Minocin

object_name: periodontitis


subject: UMLS:C3248648

subject_name: Injection, minocycline hydrochloride, 1 mg administered


subject: UMLS:C3827188

object_name: melanoma


subject: UMLS:C3827188

object_name: Effects of immunotherapy


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Cryptococcal meningitis


subject: CHEBI:63613

subject_name: Nevirapine


subject: UMLS:C4078830

object_name: anthrax disease


subject: UMLS:C4224859

subject_name: Anthim


subject: UNII:S173RED00L

subject_name: Otamixaban

object_name: acute coronary syndrome


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: Humoral rejection


subject: UMLS:C4329319

subject_name: Anti-CSF1 Monoclonal Antibody PD-0360324

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C4329319

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C4329319

object_name: Recurrent ovarian cancer


subject: UMLS:C0445115

subject_name: Normal saline

object_name: urothelial carcinoma


subject: UMLS:C4526709

subject_name: Personalized Genomic Vaccine 001


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: CHEBI:8499

subject_name: Propranolol

object_name: tetralogy of fallot


subject: CHEBI:8499

object_name: double outlet right ventricle


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:4672

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:47898

subject_name: Epirubicin


subject: CHEBI:47898

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:47898

object_name: Breast cancer stage III


subject: CHEBI:47898


subject: CHEBI:47898

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: UMLS:C1705207


subject: UMLS:C1705207


subject: UMLS:C1705207


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: acquired idiopathic inflammatory myopathy


subject: UNII:4EQZ6YO2HI

object_name: idiopathic inflammatory myopathy


subject: UNII:4EQZ6YO2HI

object_name: Osteopenia/osteoporosis


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UMLS:C2985186

object_name: pancreatic neoplasm


subject: UMLS:C2985186

object_name: exocrine pancreatic carcinoma


subject: UMLS:C2985186

object_name: malignant pancreatic neoplasm


subject: CHEBI:74705

subject_name: Met-Leu

object_name: juvenile idiopathic arthritis


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: PUBCHEM.COMPOUND:16681698

subject_name: Obatoclax mesylate

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: prolymphocytic leukemia


subject: PUBCHEM.COMPOUND:16681698

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:16681698

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:16681698

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:16681698

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: CHEBI:94522


subject: UNII:39200FJ43J

subject_name: [OBSOLETE] obatoclax mesylate


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UNII:39200FJ43J


subject: UMLS:C1831948

subject_name: obatoclax mesylate


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1831948


subject: UMLS:C1815293

subject_name: Complete, Multiple Vitamins with Iron


subject: UMLS:C1321801

subject_name: Fiber brand of calcium polycarbophil


subject: UMLS:C0225326

subject_name: fiber


subject: CHEBI:36219

subject_name: lactose


subject: CHEBI:36218

subject_name: beta-lactose


subject: UMLS:C1260222

subject_name: Saccharum lactis, Homeopathic preparation


subject: UMLS:C1696723

subject_name: lactose - non-drug agent


subject: CHEBI:8080

subject_name: Phentermine

object_name: Drug-induced obesity


subject: UMLS:C3490349

object_name: liver failure


subject: CHEBI:114785

subject_name: Erlotinib

object_name: adult lymphoma


subject: CHEBI:114785

object_name: lymphoma


subject: CHEBI:114785

object_name: pediatric lymphoma


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: UMLS:C2987383

object_name: Solid Neoplasm


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: UMLS:C2987383


subject: PUBCHEM.COMPOUND:90488848

object_name: diabetic kidney disease


subject: PUBCHEM.COMPOUND:90488848

object_name: nephrotic syndrome


subject: PUBCHEM.COMPOUND:90488848

object_name: Nephrotic Syndrome, CTCAE


subject: GTOPDB:1331

subject_name: ACTH


subject: GTOPDB:1331


subject: GTOPDB:1331


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: UMLS:C3539087


subject: UMLS:C3539087


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:3892


subject: CHEBI:3892


subject: UNII:85I4FF980A

object_name: nephrolithiasis


subject: CHEBI:49005

subject_name: Deferasirox

object_name: hemolytic anemia


subject: CHEBI:49005

object_name: non-autoimmune hemolytic anemia


subject: UMLS:C0971122

subject_name: ICL 670A


subject: UMLS:C0971122


subject: CHEBI:4356

subject_name: Deferoxamine


subject: CHEBI:4356


subject: UMLS:C4547004

object_name: acute liver failure


subject: CHEBI:6801

subject_name: Metformin

object_name: Increased reactive oxygen species production


subject: UNII:FQE44HS7AH

subject_name: Piclozotan

object_name: Parkinson disease


subject: CHEBI:135966

subject_name: Carisbamate

object_name: alcohol abuse


subject: CHEBI:135966

object_name: alcohol dependence


subject: CHEBI:135966

object_name: Harmful pattern of substance use


subject: CHEBI:135966

object_name: substance abuse


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Memory observations


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: Ambulation Difficulty


subject: PUBCHEM.COMPOUND:52943456

subject_name: FONDAPARINUX

object_name: acute coronary syndrome


subject: CHEBI:61033

subject_name: Fondaparinux


subject: CHEBI:8382

subject_name: Prednisone

object_name: hepatitis C


subject: CHEBI:230956

object_name: cystic fibrosis


subject: CHEBI:45307

subject_name: Seliciclib


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Duchenne muscular dystrophy


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: CHEBI:183660

subject_name: Acetildenafil


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: CHEBI:9139

subject_name: Sildenafil


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: precancerous condition


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Vaso-Occlusive Crisis


subject: UMLS:C0700599

object_name: Hemoglobin SS disease with crisis


subject: CHEBI:131327


subject: CHEBI:131327


subject: CHEBI:2674

subject_name: Amodiaquine


subject: CHEBI:2674


subject: CHEBI:63609

subject_name: mefloquine


subject: CHEBI:63609


subject: CHEBI:63918

subject_name: Artesunate


subject: CHEBI:63918


subject: CHEBI:125427

object_name: castration-resistant prostate carcinoma


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:47519

subject_name: Ketoconazole


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:66910

subject_name: Axitinib

object_name: paraganglioma


subject: CHEBI:66910

object_name: adrenal gland pheochromocytoma


subject: CHEBI:66910

object_name: pheochromocytoma


subject: UMLS:C1328149


subject: UMLS:C1328149


subject: UMLS:C1328149


subject: CHEBI:47519

object_name: Childhood Neuroblastoma


subject: CHEBI:47519

object_name: neuroblastoma


subject: CHEBI:47519

object_name: Neuroblastoma recurrent


subject: CHEBI:143658


subject: UMLS:C0731141

subject_name: GTN

object_name: migraine


subject: UMLS:C0731141

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C0591362

subject_name: Diamox


subject: UMLS:C0591362


subject: CHEBI:9635

subject_name: Toremifene

object_name: ovarian cancer


subject: CHEBI:9635

object_name: ovarian neoplasm


subject: CHEBI:9635

object_name: ovarian carcinoma


subject: UMLS:C2744652

object_name: skin disease caused by bacterial infection


subject: UMLS:C2744652

object_name: cellulitis


subject: UNII:L7451S9126

subject_name: Crizanlizumab

object_name: myelofibrosis


subject: UMLS:C4329340

subject_name: Nisevokitug


subject: UNII:15KFN616FK

subject_name: Rineterkib


subject: GTOPDB:12361

subject_name: sabatolimab


subject: UNII:3L7R886Y06

subject_name: SABATOLIMAB


subject: UMLS:C4085985


subject: UNII:0282IF4JC8

subject_name: Siremadlin


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: ulcerative colitis


subject: CHEBI:229233

object_name: inflammatory bowel disease 1


subject: UNII:3X8387Q25N


subject: UNII:3X8387Q25N


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: non-small cell lung carcinoma


subject: CHEBI:5818

subject_name: Hydroxyzine

object_name: Anxiety symptoms


subject: CHEBI:5818

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:5818

object_name: Anxiety, CTCAE 5.0


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: Coronary artery disease progression


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654

object_name: malignant epithelial tumor of ovary


subject: UMLS:C3640943


subject: UNII:5ZHA5P4PFX

subject_name: Dalpiciclib

object_name: malignant soft tissue neoplasm


subject: UNII:5ZHA5P4PFX

object_name: sarcoma


subject: UMLS:C4287766

object_name: neoplastic meningitis


subject: CHEBI:84500

subject_name: varenicline

object_name: periodontitis


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:6801

subject_name: Metformin

object_name: Bone loss in jaw


subject: GTOPDB:13582

object_name: bacterial pneumonia


subject: GTOPDB:13582

object_name: Community-Acquired Pneumonia


subject: CHEBI:9241

subject_name: Spironolactone

object_name: wet macular degeneration


subject: CHEBI:32135

subject_name: Soblidotin

object_name: lung cancer


subject: CHEBI:32135

object_name: lung neoplasm


subject: CHEBI:32135

object_name: lung carcinoma


subject: CHEBI:8378

subject_name: Prednisolone

object_name: King's Evil


subject: RXCUI:371024

subject_name: antipyrine / benzocaine Otic Solution

object_name: asthma


subject: CHEBI:229764

subject_name: Selinexor

object_name: Post-polycythemia vera myelofibrosis


subject: CHEBI:229764


subject: CHEBI:229764

object_name: myelofibrosis


subject: PUBCHEM.COMPOUND:6918224

subject_name: QUETIAPINE FUMARATE

object_name: schizoaffective disorder


subject: PUBCHEM.COMPOUND:6918224

object_name: schizophrenia 18


subject: CHEBI:9150

subject_name: Simvastatin

object_name: uveitis


subject: CHEBI:9150

object_name: Uveitis, CTCAE


subject: UMLS:C4294362

subject_name: (SPL REVIEW) Clobetasol Propionate .05 mg in 100 mL TOPICAL LOTION

object_name: Umbilical granuloma


subject: UMLS:C1321600

subject_name: Silver nitrate stain


subject: CHEBI:32130

subject_name: Silver nitrate


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: Vaccine response impaired


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: CHEBI:6532

subject_name: Loperamide


subject: CHEBI:107736

subject_name: Metoclopramide


subject: UMLS:C0699913

subject_name: Maxolon


subject: CHEBI:7507

subject_name: Framycetin


subject: CHEBI:28001

subject_name: Vancomycin


subject: MESH:D022341

subject_name: Yellow Fever Vaccine


subject: UMLS:C5887900

subject_name: Yellow fever virus antigen only vaccine product


subject: CHEMBL.COMPOUND:CHEMBL2108816

subject_name: YELLOW FEVER VACCINE


subject: UMLS:C2356374

subject_name: yellow fever virus strain 17D-204 live antigen


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Plexosarcoma


subject: PUBCHEM.COMPOUND:43805

object_name: Childhood Gastrointestinal Stromal Tumor


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C3641791


subject: UMLS:C3641791


subject: UMLS:C3641791

object_name: pancreatic neoplasm


subject: UMLS:C3641791

object_name: exocrine pancreatic carcinoma


subject: UMLS:C3641791

object_name: malignant pancreatic neoplasm


subject: UMLS:C3641791

object_name: colorectal cancer


subject: UMLS:C3641791

object_name: colorectal carcinoma


subject: UMLS:C3641791

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641791

object_name: carcinoma of esophagus


subject: UMLS:C3641791

object_name: esophageal cancer


subject: UMLS:C3641791

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C3641791

object_name: neoplasm of esophagus


subject: UMLS:C3641791

object_name: Stomach cancer


subject: UMLS:C3641791

object_name: gastric cancer


subject: UMLS:C3641791

object_name: rectal carcinoma


subject: UMLS:C3641791

object_name: rectal cancer


subject: UMLS:C3641791

object_name: Childhood Rectal Carcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Plexosarcoma


subject: MESH:C520255

object_name: Childhood Gastrointestinal Stromal Tumor


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:16480

subject_name: Nitric Oxide

object_name: bronchiolitis


subject: PUBCHEM.COMPOUND:2269

object_name: Ureaplasma urethritis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: CHEBI:2955

subject_name: Azithromycin


subject: UMLS:C5853392

object_name: alpha 1-antitrypsin deficiency


subject: CHEBI:8871

subject_name: Risperidone

object_name: Psychostimulant dependence


subject: MESH:C000657361

subject_name: yi-zhi-an-shen

object_name: Cognitive impairment


subject: CHEBI:31355

subject_name: Carboplatin

object_name: choroid plexus carcinoma


subject: CHEBI:31355

object_name: choroid plexus papilloma


subject: CHEBI:31355

object_name: atypical choroid plexus papilloma


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:37690

subject_name: allose

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130

object_name: major depressive disorder


subject: CHEBI:24848

subject_name: inositol

object_name: neural tube defect


subject: CHEBI:24848

object_name: neural tube defects, susceptibility to


subject: CHEBI:7726

subject_name: octreotide

object_name: alcoholic liver cirrhosis


subject: CHEBI:135905

subject_name: Terlipressin


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Microvascular coronary artery disease


subject: CHEBI:8988

object_name: Locally Advanced Soft Tissue Sarcoma


subject: CHEBI:8988

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:8988

object_name: Recurrent Soft Tissue Sarcoma


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C5666958

subject_name: FAP/CD40-targeting DARPin MP0317

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:73617

subject_name: Phe-Ala-Pro


subject: UMLS:C5238987

object_name: urothelial carcinoma


subject: UMLS:C5238987

object_name: transitional cell carcinoma


subject: UMLS:C5238987

object_name: renal carcinoma


subject: UMLS:C5238987

object_name: renal cell carcinoma


subject: UMLS:C5238987

object_name: melanoma


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies


subject: UMLS:C0003250


subject: UMLS:C0003250


subject: UMLS:C0003250


subject: UMLS:C0003250


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: CHEBI:8426

subject_name: Probenecid

object_name: Abdominal Infection


subject: UMLS:C5203993

subject_name: Antifungal PC945

object_name: cystic fibrosis


subject: UNII:3S252O2Z4X

subject_name: Emapalumab

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UNII:3S252O2Z4X

object_name: aplastic anemia


subject: UNII:3S252O2Z4X

object_name: idiopathic aplastic anemia


subject: UNII:3S252O2Z4X

object_name: Bone marrow depression


subject: UMLS:C4740903

subject_name: emapalumab-lzsg


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: UMLS:C4740903


subject: CHEBI:31515

subject_name: Domperidone

object_name: Pediatric Disorder


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:13559282

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:13559282

object_name: breast cancer


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:71025


subject: CHEBI:71025


subject: CHEBI:17823

subject_name: Calcitriol

object_name: rickets


subject: PUBCHEM.COMPOUND:44151801

subject_name: Degarelix


subject: PUBCHEM.COMPOUND:44151801

object_name: Androgen Receptor Positive


subject: UMLS:C0971731


subject: UMLS:C0971731


subject: CHEBI:175901

subject_name: Gemcitabine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767

object_name: Oral Mucositis


subject: PUBCHEM.COMPOUND:2767

object_name: stomatitis


subject: PUBCHEM.COMPOUND:2767

object_name: oral mucositis


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C3815568

object_name: Neck Carcinoma


subject: UMLS:C3815568

object_name: head and neck neoplasm


subject: UMLS:C3815568

object_name: head and neck cancer


subject: UMLS:C3815568


subject: UMLS:C3815568


subject: UMLS:C3815568


subject: CHEBI:15551

subject_name: Dinoprostone

object_name: Failed medical or unspecified induction of labor


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin

object_name: endometrial cancer


subject: UNII:7R7G6EH5UL

object_name: uterine corpus cancer


subject: UNII:7R7G6EH5UL

object_name: endometrial carcinoma


subject: UMLS:C3653444

subject_name: Corticosteroid derivatives, antimigraine drugs

object_name: aspiration; mucus in respiratory tract


subject: CHEBI:67272

subject_name: Perifosine

object_name: ovarian cancer


subject: CHEBI:67272

object_name: ovarian neoplasm


subject: CHEBI:67272

object_name: ovarian carcinoma


subject: UNII:5Q6TZN2HNM

subject_name: Ecallantide

object_name: Intraoperative Hemorrhage


subject: CHEBI:85993

subject_name: Palbociclib

object_name: acute lymphoblastic leukemia


subject: CHEBI:85993

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:85993

object_name: acute myeloid leukemia


subject: UNII:E3B2GI648A

subject_name: Belatacept

object_name: Infection of transplanted kidney


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Advanced chronic liver disease


subject: UNII:59WCJ0YNWM

subject_name: Idalopirdine

object_name: schizophrenia


subject: UMLS:C3253508


subject: PR:000008621

subject_name: minor histocompatibility antigen H13

object_name: type 1 diabetes mellitus


subject: UniProtKB:O74800

subject_name: IMP1_SCHPO Mitochondrial inner membrane protease subunit 1 (sprot)


subject: PR:000008944

subject_name: insulin-like growth factor 2 mRNA-binding protein 2


subject: PR:000015566

subject_name: signal peptide peptidase-like 3


subject: PR:000005679

subject_name: bifunctional coenzyme A synthase

object_name: Anterior Cerebral Circulation Infarction


subject: PR:000005679

object_name: Cerebrovascular Occlusion


subject: PR:000011476

subject_name: cytosolic Fe-S cluster assembly factor NUBP1


subject: PR:000011476


subject: CHEMBL.COMPOUND:CHEMBL4297877

subject_name: BALSTILIMAB

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297877

object_name: pediatric lymphoma


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: UMLS:C4526708


subject: PUBCHEM.COMPOUND:60751

subject_name: Temoporfin

object_name: head and neck squamous cell carcinoma


subject: CHEBI:9437


subject: UNII:LMQ24G57E9

subject_name: Daridorexant

object_name: Postoperative delirium


subject: UNII:LMQ24G57E9

object_name: Emergence Delirium


subject: UNII:LMQ24G57E9

object_name: Postoperative cognitive dysfunction


subject: UMLS:C0206948

subject_name: gatorade

object_name: gastroenteritis


subject: CHEBI:32696

object_name: proteinuria


subject: CHEBI:32696

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:32696

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:32696

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:32696

object_name: Drug-induced Nephropathy


subject: CHEBI:32696

object_name: hypertension


subject: CHEBI:32696

object_name: Hypertension, CTCAE


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: UMLS:C3641177

subject_name: PEG-3350/Sodium Sulfate/Sodium Chloride/Potassium Chloride/Sodium Ascorbate/Ascorbic Acid-based Laxative

object_name: colorectal cancer


subject: UMLS:C3641177

object_name: colorectal carcinoma


subject: UMLS:C3641177

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Adverse reaction caused by dapagliflozin


subject: MESH:C000709210

object_name: fibromyalgia


subject: CHEBI:16755

subject_name: chenodiol

object_name: Bile acid malabsorption


subject: CHEBI:16755

object_name: cholelithiasis


subject: UMLS:C1831964

object_name: neoplasm


subject: UNII:7D0YB67S97

subject_name: Abatacept

object_name: pemphigus vulgaris


subject: UMLS:C1250042

subject_name: oxytocin nasal spray

object_name: Loneliness


subject: PUBCHEM.COMPOUND:66964417

subject_name: LACTULOSE

object_name: Sepsis


subject: PUBCHEM.COMPOUND:66964417

object_name: Sepsis, CTCAE


subject: PUBCHEM.COMPOUND:66964417

object_name: perinatal necrotizing enterocolitis


subject: PUBCHEM.COMPOUND:66964417

object_name: necrotizing enterocolitis


subject: PUBCHEM.COMPOUND:66964417

object_name: Necrotizing Enterocolitis, AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:9U7D5QH5AE


subject: UNII:97I1C92E55

subject_name: CEFIXIME

object_name: Liver Abscess


subject: CHEBI:472657

subject_name: Cefixime


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Plexosarcoma


subject: UMLS:C5959690

subject_name: Anti-EGFR/CD3 Bispecific Antibody SMET12

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: MESH:D009539

subject_name: Nicotinic Acids

object_name: hyperphosphatemia


subject: MESH:D009539

object_name: Serum phosphate concentrations above normal (finding)


subject: MESH:D009539

object_name: Hyperphosphatemia, CTCAE


subject: UMLS:C1701110

subject_name: Zactima

object_name: glioblastoma


subject: UMLS:C1701110

object_name: Childhood Glioblastoma


subject: UMLS:C1701110

object_name: adult glioblastoma


subject: UMLS:C1701110

object_name: Adult Gliosarcoma


subject: UMLS:C1701110

object_name: gliosarcoma


subject: UMLS:C1701110

object_name: Childhood Gliosarcoma


subject: CHEBI:194146

object_name: Childhood Soft Tissue Sarcoma


subject: CHEBI:194146

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:194146

object_name: sarcoma


subject: CHEBI:194146

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:194146

object_name: soft tissue sarcoma


subject: UMLS:C3714111

object_name: leukopenia


subject: PUBCHEM.COMPOUND:123610

subject_name: Eptifibatide

object_name: Non-ST Elevated Myocardial Infarction


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: Stomach cancer


subject: UMLS:C4086499

object_name: gastric cancer


subject: UMLS:C3272996

subject_name: p.DOM-WT1-37 DNA Vaccine

object_name: acute promyelocytic leukemia


subject: UMLS:C3272996

object_name: acute lymphoblastic leukemia


subject: UMLS:C3272996

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3272996

object_name: acute myeloid leukemia


subject: UMLS:C3272996

object_name: chronic leukemia


subject: UMLS:C3272996

object_name: acute leukemia


subject: UMLS:C3272997

subject_name: p.DOM-WT1-126 DNA Vaccine


subject: UMLS:C3272997


subject: UMLS:C3272997


subject: UMLS:C3272997


subject: UMLS:C3272997


subject: UMLS:C3272997


subject: CHEBI:57694

object_name: Polyneuropathies and other disorders of the peripheral nervous system


subject: CHEBI:16243

subject_name: Quercetin


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: plasmacytoma


subject: UMLS:C1709429


subject: PUBCHEM.COMPOUND:23667621

subject_name: DEXAMETHASONE SODIUM PHOSPHATE

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:23667621

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:23667621


subject: UNII:7R7G6EH5UL

subject_name: Navtemadlin


subject: UNII:7R7G6EH5UL


subject: UNII:7R7G6EH5UL


subject: CHEMBL.COMPOUND:CHEMBL4297772

object_name: HIV infection


subject: UMLS:C0939232

subject_name: fluticasone / salmeterol

object_name: asthma


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: malignant neoplasm of breast stage IIb


subject: CHEBI:41774

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:41774

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:4VBL71TY4Y

subject_name: SAFFLOWER

object_name: hypertensive heart disease


subject: UMLS:C1443192

subject_name: Carthamus tinctorius antigen


subject: CHEMBL.COMPOUND:CHEMBL1201660

subject_name: SAFFLOWER OIL


subject: UNII:T74V9O0Y2W

object_name: irritable bowel syndrome


subject: CHEBI:70839

subject_name: Dasatinib

object_name: salivary gland adenoid cystic carcinoma


subject: CHEBI:70839

object_name: salivary gland cancer


subject: CHEBI:70839

object_name: Stage IV Major Salivary Gland Cancer AJCC v7


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UMLS:C0042210

subject_name: Vaccines

object_name: Infection caused by Norovirus


subject: UMLS:C0042210

object_name: Viral gastroenteritis caused by Norwalk-like agent


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: CHEBI:45716

subject_name: Vorinostat

object_name: adult acute myeloid leukemia


subject: CHEBI:45716

object_name: childhood acute myeloid leukemia


subject: MESH:C000654308

object_name: allergic asthma


subject: MESH:C000654308

object_name: IgE-mediated allergic asthma


subject: MESH:C000654308

object_name: extrinsic asthma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED

object_name: HER2 positive


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEMBL.COMPOUND:CHEMBL1743042

subject_name: MOTAVIZUMAB

object_name: congenital heart disease


subject: UMLS:C1667763


subject: CHEBI:31859

subject_name: Modafinil

object_name: Childhood Breast Carcinoma


subject: CHEBI:31859

object_name: breast carcinoma


subject: CHEBI:31859

object_name: breast cancer


subject: CHEBI:31859

object_name: prostate cancer


subject: CHEBI:31859

object_name: prostate neoplasm


subject: UMLS:C4743169

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:74061

subject_name: Ile-Arg

object_name: Tourette syndrome


subject: CHEBI:49666

subject_name: iridium atom


subject: PR:000009064

subject_name: insulin receptor


subject: PUBCHEM.COMPOUND:3367

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: neoplasm of esophagus


subject: UMLS:C4053586

subject_name: NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301

object_name: lung cancer


subject: UMLS:C4053586

object_name: lung neoplasm


subject: UMLS:C4053586

object_name: lung carcinoma


subject: UMLS:C4053586

object_name: bladder tumor


subject: UMLS:C4053586

object_name: urinary bladder carcinoma


subject: UMLS:C4053586

object_name: urinary bladder cancer


subject: UMLS:C4053586

object_name: childhood bladder carcinoma


subject: UMLS:C4053586

object_name: liver cancer


subject: UMLS:C4053586

object_name: liver neoplasm


subject: UMLS:C4053586


subject: UMLS:C4053586

object_name: liver carcinoma


subject: UMLS:C4053586

object_name: carcinoma of esophagus


subject: UMLS:C4053586

object_name: esophageal cancer


subject: UMLS:C4053586


subject: UMLS:C4053586


subject: UMLS:C4053586

object_name: ovarian cancer


subject: UMLS:C4053586

object_name: ovarian neoplasm


subject: UMLS:C4053586

object_name: ovarian carcinoma


subject: UMLS:C4053586

object_name: Childhood Synovial Sarcoma


subject: UMLS:C4053586

object_name: Adult Synovial Sarcoma


subject: UMLS:C4053586

object_name: synovial sarcoma


subject: UMLS:C4053586

object_name: melanoma


subject: UMLS:C1714033

subject_name: wheat dextrin

object_name: Androgen excess


subject: UMLS:C1714033

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1714033

object_name: metabolic syndrome X


subject: CHEBI:74705

subject_name: Met-Leu

object_name: EXCESS LMW-DNA


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:95165

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:95165

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: UMLS:C0728960

subject_name: Analgesic brand of acetaminophen-phenyltoloxamine

object_name: pain agnosia


subject: UMLS:C0728960

object_name: Pain insensitivity


subject: UNII:4YRW73H69V

subject_name: LYSOZYME HYDROCHLORIDE

object_name: Chronic obstructive pulmonary disease of horses


subject: UNII:4YRW73H69V

object_name: COPD, severe early onset


subject: UNII:4YRW73H69V

object_name: chronic obstructive pulmonary disease


subject: PUBCHEM.COMPOUND:91976556

subject_name: Muramidase


subject: PUBCHEM.COMPOUND:91976556


subject: PUBCHEM.COMPOUND:91976556


subject: UMLS:C3475231

subject_name: lysozyme hydrochloride


subject: UMLS:C3475231


subject: UMLS:C3475231


subject: MESH:D000090984

object_name: juvenile idiopathic arthritis


subject: MESH:D000090984

object_name: rheumatoid arthritis


subject: MESH:D000090984

object_name: multiple sclerosis


subject: MESH:D000090984


subject: MESH:D000090984

object_name: Systemic lupus erythematosus, childhood onset


subject: MESH:D000090984

object_name: pemphigus vulgaris


subject: UMLS:C5575181

subject_name: Janssen COVID-19 Vaccine


subject: UMLS:C5575181


subject: UMLS:C5575181


subject: UMLS:C5575181


subject: UMLS:C5575181


subject: UMLS:C5575181


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: UNII:JSV288Q5CV


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:138016

subject_name: MPA


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:138016


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:168396


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: CHEBI:6715


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: PR:000012478


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: UniProtKB:P27664


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: UniProtKB:P47802

subject_name: MTX1_MOUSE Metaxin-1 (sprot)


subject: UniProtKB:P47802


subject: UniProtKB:P47802


subject: UniProtKB:P47802


subject: PR:000010755


subject: PR:000010755


subject: PR:000010755


subject: PR:000010755


subject: UNII:82MI0GT75Z

object_name: traumatic encephalopathy


subject: MESH:C526315


subject: CHEBI:131701

subject_name: poly(ethylene terephthalate)(1-)


subject: UMLS:C0935952

subject_name: Oncophage

object_name: glioma susceptibility 1


subject: UMLS:C0935952

object_name: ependymoma


subject: UMLS:C0935952

object_name: childhood ependymoma


subject: UMLS:C0935952

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C0935952

object_name: Adult Ependymoma


subject: UMLS:C0935952

object_name: anaplastic ependymoma


subject: UMLS:C0935952

object_name: adult anaplastic ependymoma


subject: UMLS:C0935952

object_name: Childhood Anaplastic Ependymoma


subject: UMLS:C0935952

object_name: clear cell ependymoma


subject: UMLS:C0935952

object_name: anaplastic astrocytoma


subject: UMLS:C0935952

object_name: Brain Stem Glioblastoma


subject: MESH:C551853

subject_name: Viusid

object_name: lung disorder


subject: MESH:C551853

object_name: History of - respiratory disease


subject: MESH:C551853

object_name: kidney disorder


subject: MESH:C551853

object_name: liver disorder


subject: MESH:C551853

object_name: diabetes mellitus


subject: MESH:C551853

object_name: heart disorder


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: hip pain chronic


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Hip arthropathy


subject: CHEBI:4466


subject: CHEBI:4466

object_name: osteoarthritis, hip


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: GTOPDB:13273

object_name: kidney failure


subject: UMLS:C5706477

subject_name: Relaxin Mimetic AZD5462


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: cardiac conduction defect


subject: CHEBI:26710

object_name: Schnyder corneal dystrophy


subject: CHEBI:26710

object_name: spondylocostal dysostosis


subject: CHEBI:26710

object_name: systemic primary carnitine deficiency disease


subject: CHEBI:26710

object_name: sickle cell disease


subject: CHEBI:36791

subject_name: Escitalopram

object_name: chronic hepatitis C virus infection


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:31797

subject_name: Gadolinium DTPA

object_name: myocardial infarction


subject: CHEBI:31797

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:31797

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:180856

subject_name: Hovenoside G


subject: CHEBI:180856


subject: CHEBI:180856


subject: UMLS:C0721529

subject_name: Magnevist


subject: UMLS:C0721529


subject: UMLS:C0721529


subject: CHEBI:6121

subject_name: Ketamine

object_name: Femoral head necrosis


subject: CHEBI:6121

object_name: osteoarthritis, knee


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: osteonecrosis


subject: CHEBI:39548

object_name: avascular necrosis


subject: CHEBI:39548

object_name: Ischemic Necrosis


subject: CHEBI:39548

object_name: Avascular Necrosis, CTCAE


subject: UMLS:C5882212

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5882212

object_name: Obesity, CTCAE


subject: UMLS:C5882212

object_name: Overweight and obesity


subject: UMLS:C4683835

object_name: neoplasm


subject: UMLS:C5557246

subject_name: KRAS G12C Inhibitor LY3537982

object_name: Neoplasm Metastasis


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:1805

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:1805

object_name: ovarian carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: stage IV cutaneous squamous cell carcinoma of the head and neck


subject: UNII:DPT0O3T46P

object_name: stage III cutaneous squamous cell carcinoma of the head and neck


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UMLS:C5848866

object_name: Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5848866

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: UMLS:C5848866


subject: UMLS:C5848866


subject: PUBCHEM.COMPOUND:3085828

subject_name: Gadoteric acid

object_name: Meniere disease


subject: CHEBI:86285

object_name: pulmonary hypertension


subject: CHEBI:86285

object_name: pulmonary artery hypoplasia


subject: CHEBI:86285

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:86285

object_name: pulmonary arterial hypertension


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: PUBCHEM.COMPOUND:53394576


subject: UNII:349552KRHK

subject_name: Simendan

object_name: myocardial stunning


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: UMLS:C0020172

subject_name: Humulin S

object_name: type 2 diabetes mellitus


subject: CHEBI:5134

subject_name: Fluticasone

object_name: bronchiolitis


subject: UMLS:C1328728

object_name: cutaneous leishmaniasis


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: prostate carcinoma


subject: CHEBI:34385

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:9846339

subject_name: Gallium Maltolate

object_name: glioblastoma


subject: PUBCHEM.COMPOUND:9846339

object_name: Childhood Glioblastoma


subject: PUBCHEM.COMPOUND:9846339

object_name: adult glioblastoma


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: UNII:17LEI49C2G


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Stomach cancer


subject: CHEBI:3215

object_name: gastric cancer


subject: CHEBI:3215

object_name: gastric adenoma


subject: CHEBI:26710

subject_name: Sodium chloride


subject: CHEBI:26710


subject: CHEBI:26710


subject: CHEBI:131532

subject_name: pyridoxamine dihydrochloride


subject: CHEMBL.COMPOUND:CHEMBL4298078

subject_name: PYRIDOXAMINE DIHYDROCHLORIDE


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Hyperglycemia steroid-induced


subject: CHEBI:85188

subject_name: paritaprevir

object_name: Compensated cirrhosis


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1328703

object_name: ovarian cancer


subject: UMLS:C1328703

object_name: ovarian neoplasm


subject: UMLS:C1328703

object_name: ovarian carcinoma


subject: UMLS:C0879396

object_name: bladder tumor


subject: UMLS:C0879396

object_name: urinary bladder carcinoma


subject: UMLS:C0879396

object_name: urinary bladder cancer


subject: UMLS:C0879396

object_name: childhood bladder carcinoma


subject: UMLS:C0907857

subject_name: collagen-PVP


subject: UMLS:C1176287

subject_name: Cimicifuga racemosa, flower essences

object_name: Menopause present (finding)


subject: UMLS:C1176287

object_name: Menopause


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Pelvic abscess


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: UMLS:C0599685

subject_name: Anti-Retroviral Agents

object_name: Human immunodeficiency virus II infection


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Squamous cell carcinoma of the oral cavity stage I


subject: UNII:28X28X9OKV

object_name: Squamous cell carcinoma of the oral cavity stage II


subject: UNII:28X28X9OKV

object_name: Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: UNII:28X28X9OKV

object_name: Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7


subject: UNII:28X28X9OKV

object_name: human papilloma virus infection


subject: UNII:28X28X9OKV

object_name: Oropharyngeal squamous cell carcinoma stage I


subject: UNII:28X28X9OKV

object_name: Stage IVC Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UNII:28X28X9OKV

object_name: Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: GTOPDB:8221

subject_name: epacadostat

object_name: Small cell lung cancer extensive stage


subject: UNII:2HR315841W


subject: CHEBI:3757

subject_name: Clonidine

object_name: cholesteatoma


subject: MESH:D003487

subject_name: Cyanoacrylates

object_name: Donor site complication


subject: CHEBI:30356

subject_name: isobutyl group


subject: GTOPDB:4453

subject_name: thrombin


subject: CHEBI:9574

subject_name: Thrombin


subject: UMLS:C1337342

subject_name: thrombin, bovine


subject: UMLS:C0040018


subject: UNII:T432289GYZ

subject_name: Sinecatechins

object_name: HIV infection


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate

object_name: cesarean section; complications


subject: CHEBI:60789

object_name: Drug-induced hypotension


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:18357

subject_name: Norepinephrine


subject: PUBCHEM.COMPOUND:11957447

subject_name: NOREPINEPHRINE BITARTRATE


subject: PUBCHEM.COMPOUND:11957447


subject: UMLS:C3274574

subject_name: Conmana

object_name: non-small cell lung carcinoma


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Stage I Prostate Cancer AJCC v6


subject: CHEBI:39548

object_name: Prostate cancer stage I


subject: CHEBI:39548

object_name: Stage I Prostate Cancer AJCC v8


subject: CHEBI:39548

object_name: Stage I Prostate Cancer AJCC v7


subject: CHEBI:39548

object_name: Stage IV Prostate Cancer AJCC v6


subject: CHEBI:39548

object_name: Carcinoma of the prostate stage IV


subject: CHEBI:39548

object_name: Stage IV Prostate Cancer AJCC v7


subject: CHEBI:39548

object_name: Stage IV Prostate Cancer AJCC v8


subject: CHEBI:39548

object_name: Prostate cancer recurrent


subject: CHEBI:39548

object_name: Stage IIA Prostate Cancer AJCC v7


subject: CHEBI:39548

object_name: Stage IIA Prostate Cancer AJCC v8


subject: CHEBI:39548

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEBI:39548

object_name: Stage III Prostate Cancer AJCC v7


subject: CHEBI:39548

object_name: Carcinoma of the prostate stage III


subject: CHEBI:39548

object_name: Stage III Prostate Cancer AJCC v6


subject: CHEBI:39548

object_name: Stage IIB Prostate Cancer AJCC v8


subject: CHEBI:39548

object_name: Stage IIB Prostate Cancer AJCC v7


subject: UMLS:C0013162

subject_name: Drug Combinations

object_name: hyperlipoproteinemia


subject: UMLS:C0013162

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C0013162

object_name: Serum lipids high (finding)


subject: PR:000012622

subject_name: membrane-associated progesterone receptor component 1

object_name: Paresis


subject: PR:000012622

object_name: Muscle weakness


subject: PR:000012622

object_name: Critical Illness


subject: PR:000012622

object_name: sarcopenia


subject: CHEBI:17203

subject_name: Proline


subject: CHEBI:17203


subject: CHEBI:17203


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Mesothelioma


subject: CHEBI:45716

object_name: mesothelial neoplasm


subject: CHEBI:45716

object_name: malignant mesothelioma


subject: CHEBI:75431

subject_name: ghrelin

object_name: endogenous depression


subject: DRUGBANK:DB11895

subject_name: Lenomorelin


subject: UMLS:C0911014


subject: UNII:56X54T817Q

subject_name: CORTICORELIN OVINE TRIFLUTATE

object_name: Stress


subject: CHEBI:136037

subject_name: Corticorelin


subject: UMLS:C0251514

subject_name: Acthrel


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:44241

subject_name: Metyrapone


subject: CHEBI:29033

subject_name: Ferrous cation


subject: CHEBI:31687

subject_name: Idebenone

object_name: fibrosis


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Anxiety and fear


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Renal transplant rejection


subject: CHEBI:4031

subject_name: Cyclosporine


subject: UMLS:C2932027

object_name: atrial flutter


subject: UMLS:C2932027

object_name: Atrial Flutter by ECG Finding


subject: UMLS:C2932027

object_name: Atrial Flutter, CTCAE


subject: UMLS:C2932027

object_name: Thromboembolism of vein


subject: UMLS:C2932027

object_name: myocardial infarction


subject: UMLS:C2932027

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C2932027

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C2932027

object_name: cardiomyopathy


subject: UNII:M64JF6WMSA

subject_name: Roblitinib

object_name: liver carcinoma


subject: UMLS:C3896860


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Disease Progression


subject: GTOPDB:9758

object_name: childhood malignant neoplasm


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:95165

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:95165

object_name: Blast Phase


subject: CHEBI:95165

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:95165

object_name: Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:50131


subject: CHEBI:78543

subject_name: Ponatinib

object_name: Recurrent Acute Myeloid Leukemia


subject: CHEBI:78543

object_name: Refractory acute myeloid leukemia


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:221840


subject: CHEBI:221840


subject: CHEBI:221840


subject: CHEBI:221840

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:221840

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:221840


subject: CHEBI:221840

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:221840

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:221840

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:221840

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:221840

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:221840

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:221840

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:221840

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:221840

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:221840

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:221840

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:221840

object_name: adult acute monocytic leukemia


subject: CHEBI:221840

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:221840

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:221840

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:221840

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:221840

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:221840

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:221840

object_name: Adult Erythroleukemia


subject: CHEBI:221840

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Blast Phase


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: PUBCHEM.COMPOUND:4616292

object_name: leukemia, myeloid, accelerated-phase


subject: PUBCHEM.COMPOUND:4616292

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:4616292

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:4616292

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:4616292

object_name: T-cell adult acute lymphocytic leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Promyelocytic Leukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:4616292

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:67272

subject_name: Perifosine

object_name: Blast Phase


subject: CHEBI:67272

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:67272

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:67272

object_name: Previously Treated Myelodysplastic Syndrome


subject: CHEBI:67272

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:67272


subject: CHEBI:67272

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:67272

object_name: Adult Acute Promyelocytic Leukemia with PML-RARA


subject: CHEBI:67272

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:67272

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:67272

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:67272

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:67272

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:67272

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:67272

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:67272

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:67272

object_name: Untreated Adult Acute Lymphoblastic Leukemia


subject: CHEBI:67272

object_name: adult acute monocytic leukemia


subject: CHEBI:67272

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:67272

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:67272

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:67272

object_name: Adult Acute Promyelocytic Leukemia


subject: CHEBI:67272

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:67272

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:67272

object_name: Adult Erythroleukemia


subject: CHEBI:67272

object_name: Adult Pure Erythroid Leukemia


subject: UMLS:C1613953

object_name: Alzheimer disease


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Opioid analgesic adverse reaction


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: long COVID-19


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C1879771

object_name: Recurrent Glioblastoma


subject: CHEBI:85164

subject_name: Nintedanib


subject: CHEBI:85164


subject: UNII:67GXQ6WCC6

subject_name: Oglemilast

object_name: COPD, severe early onset


subject: UNII:67GXQ6WCC6

object_name: chronic obstructive pulmonary disease


subject: UNII:8KFO2187CP

subject_name: Ciforadenant

object_name: kidney cancer


subject: UNII:8KFO2187CP

object_name: childhood kidney cell carcinoma


subject: UMLS:C4724815

subject_name: ciforadenant


subject: UMLS:C4724815


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: UNII:4A2Y23XK11

subject_name: Lazertinib

object_name: Stage IV Lung Cancer AJCC v7


subject: UMLS:C4048796

object_name: atopic eczema


subject: PUBCHEM.COMPOUND:343523

object_name: hyperinsulinemic hypoglycemia, familial, 2


subject: CHEBI:49166

subject_name: fluorodopa F 18


subject: CHEBI:42567

subject_name: Fisetin

object_name: coronary microvascular disorder


subject: CHEBI:42567

object_name: Arterial Stiffness


subject: CHEBI:231324

subject_name: alpelisib

object_name: pancreatic neoplasm


subject: CHEBI:231324

object_name: exocrine pancreatic carcinoma


subject: CHEBI:231324

object_name: malignant pancreatic neoplasm


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2986399


subject: UMLS:C2343504

subject_name: Aralast NP


subject: UMLS:C2343504

object_name: alpha 1-antitrypsin deficiency


subject: CHEBI:192471

subject_name: Ala-Val


subject: CHEBI:84739

object_name: bacterial pneumonia


subject: CHEBI:2637

subject_name: Amikacin


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Menstrual discomfort


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Lack of sufficient daily physical activity


subject: CHEBI:7507

subject_name: Framycetin

object_name: Asymptomatic Colonization


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: neoplasm of testis


subject: CHEBI:4026

object_name: testicular cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Rotator cuff tear


subject: UMLS:C5222443

subject_name: Fulvestrant Injection

object_name: Childhood Solid Neoplasm


subject: UMLS:C5222443

object_name: Adult Solid Neoplasm


subject: UMLS:C5222443

object_name: Solid Neoplasm


subject: UMLS:C5222443

object_name: endometrial cancer


subject: UMLS:C5222443

object_name: uterine corpus cancer


subject: UMLS:C5222443

object_name: endometrial carcinoma


subject: UMLS:C5222443

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5222443

object_name: esophageal squamous cell carcinoma


subject: UMLS:C5222443

object_name: squamous cell lung carcinoma


subject: UMLS:C5222443

object_name: cervical cancer


subject: UMLS:C5222443

object_name: cervical carcinoma


subject: UMLS:C5222443

object_name: ovarian cancer


subject: UMLS:C5222443

object_name: ovarian neoplasm


subject: UMLS:C5222443

object_name: ovarian carcinoma


subject: CHEBI:82975

subject_name: Naloxegol

object_name: Post-Operative Pain


subject: DRUGBANK:DB17010

object_name: Friedreich ataxia


subject: DRUGBANK:DB17010

object_name: Friedreich ataxia 1


subject: UMLS:C5418051

subject_name: HER2-directed TLR8 Agonist SBT6050

object_name: HER2 positive colorectal cancer


subject: UMLS:C5418051

object_name: HER2 positive breast carcinoma


subject: UMLS:C5418051

object_name: HER2-positive gastric cancer


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:231601

subject_name: trastuzumab


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C4287766


subject: UNII:234248D0HH

subject_name: Tucatinib


subject: UNII:E8R04MBQ04

object_name: Myelodysplasia


subject: UNII:E8R04MBQ04

object_name: Adult Myelodysplastic Syndrome


subject: UNII:E8R04MBQ04

object_name: childhood myelodysplastic syndrome


subject: UNII:E8R04MBQ04

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:E8R04MBQ04

object_name: chronic leukemia


subject: UNII:E8R04MBQ04

object_name: acute leukemia


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: UMLS:C2830202


subject: CHEBI:90942

subject_name: Ixazomib


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:90942


subject: CHEBI:61397

subject_name: Neratinib

object_name: prostate carcinoma


subject: CHEBI:61397

object_name: prostate cancer


subject: CHEBI:61397

object_name: castration-resistant prostate carcinoma


subject: CHEBI:61397

object_name: metastatic prostate carcinoma


subject: CHEBI:61397

object_name: Adenocarcinoma of the prostate metastatic


subject: PUBCHEM.COMPOUND:152165

object_name: pulmonary embolism


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:60802

subject_name: ropivacaine

object_name: thyroid tumor


subject: CHEBI:60802

object_name: thyroid cancer


subject: CHEBI:60802

object_name: goiter


subject: UMLS:C5203174

subject_name: Epinephrine Liquid Injection


subject: UMLS:C5203174


subject: UMLS:C5203174


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:28918


subject: CHEBI:50162

subject_name: motexafin gadolinium hydrate

object_name: leukemia


subject: CHEBI:50162

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:9919910

subject_name: Xcytrin


subject: PUBCHEM.COMPOUND:9919910


subject: CHEBI:33375

subject_name: Gadolinium


subject: CHEBI:33375


subject: CHEMBL.COMPOUND:CHEMBL3544910

subject_name: MOTEXAFIN GADOLINIUM


subject: CHEMBL.COMPOUND:CHEMBL3544910


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Fused vertebrae


subject: UNII:9RL37ZZ665

subject_name: Orantinib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: skin disorder


subject: CHEBI:17549

object_name: Cicatrix, Hypertrophic


subject: CHEBI:17549

object_name: plantar wart


subject: CHEBI:17549

object_name: keloid


subject: CHEBI:17549

object_name: common wart


subject: DRUGBANK:DB16611

subject_name: Tick-borne encephalitis vaccine (whole virus, inactivated)

object_name: rheumatoid arthritis


subject: DRUGBANK:DB16611

object_name: Immunosuppression


subject: DRUGBANK:DB16611

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C0593408

subject_name: Tick-borne encephalitis vaccine


subject: UMLS:C0593408


subject: UMLS:C0593408


subject: UMLS:C0594372

subject_name: Avonex

object_name: adult acute respiratory distress syndrome


subject: UMLS:C4305685

subject_name: ATG-Fresenius S

object_name: graft versus host disease


subject: CHEMBL.COMPOUND:CHEMBL2108494

subject_name: INTERFERON

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL2108494

object_name: cervical carcinoma


subject: UMLS:C3652465

subject_name: Interferon


subject: UMLS:C3652465


subject: UMLS:C0021747

subject_name: Interferons


subject: UMLS:C0021747


subject: UMLS:C0733470

subject_name: human leukocyte interferon


subject: UMLS:C0733470


subject: CHEBI:26536

subject_name: retinoic acid


subject: CHEBI:26536


subject: CHEBI:28870


subject: CHEBI:28870


subject: CHEBI:6067

subject_name: Isotretinoin


subject: CHEBI:6067


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Leukemia, Myeloid, Chronic-Phase


subject: CHEBI:79699

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:79699

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0876134

subject_name: Prevnar

object_name: streptococcal pneumonia


subject: UMLS:C0876134

object_name: nasopharyngeal disorder


subject: UMLS:C0876134

object_name: Vaccination adverse event


subject: UNII:EJQ7M98H5J

subject_name: Metadoxine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Kidney Calculi


subject: CHEBI:6129

object_name: Ureteral Calculi


subject: CHEBI:6129

object_name: ureterolithiasis


subject: GTOPDB:12918

object_name: temporal arteritis


subject: GTOPDB:12918

object_name: polymyalgia rheumatica


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: pulmonary fibrosis


subject: CHEBI:31300

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:107736

subject_name: Metoclopramide

object_name: Pregnant


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Disinhibition


subject: CHEBI:7465

object_name: Parkinson disease


subject: CHEBI:45716

subject_name: Vorinostat

object_name: nephroblastoma


subject: CHEBI:45716

object_name: Wilms tumor


subject: CHEBI:45716

object_name: childhood kidney Wilms tumor


subject: CHEBI:45716

object_name: adult germ cell tumor


subject: CHEBI:45716

object_name: germ cell tumor


subject: CHEBI:45716

object_name: childhood germ cell tumor


subject: CHEBI:45716

object_name: Germ Cell Cancer


subject: CHEBI:45716

object_name: Ewing sarcoma


subject: CHEBI:45716

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:45716

object_name: rhabdomyosarcoma


subject: CHEBI:45716

object_name: Childhood Rhabdomyosarcoma


subject: CHEBI:45716

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: CHEBI:45716

object_name: hepatoblastoma


subject: PUBCHEM.COMPOUND:44567960

subject_name: VASOACTIVE INTESTINAL PEPTIDE

object_name: migraine


subject: PUBCHEM.COMPOUND:44567960

object_name: migraine with or without aura, susceptibility to, 1


subject: PUBCHEM.COMPOUND:44567960

object_name: Headache


subject: PUBCHEM.COMPOUND:44567960

object_name: Headache, CTCAE


subject: CHEBI:80331

subject_name: Vasoactive intestinal peptide


subject: CHEBI:80331


subject: UMLS:C0042395

subject_name: vasoactive intestinal peptide


subject: UMLS:C0042395


subject: PUBCHEM.COMPOUND:70691420

subject_name: Aviptadil


subject: PUBCHEM.COMPOUND:70691420


subject: CHEBI:59594

subject_name: Colesevelam

object_name: sitosterolemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL


subject: UMLS:C0699319

subject_name: Cytoxan

object_name: graft versus host disease


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Inflammatory cardiomyopathy


subject: DRUGBANK:DB14745

subject_name: Olea europaea leaf

object_name: osteoarthritis


subject: UMLS:C1521716

subject_name: Olive antigen


subject: UMLS:C1116536

subject_name: Olive, Bach Flower Essence


subject: CHEBI:68590

subject_name: fidaxomicin

object_name: spinal cord injury


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: prostate carcinoma


subject: CHEBI:49900

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Arrhythmia


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: Macular Edema


subject: CHEBI:9667

subject_name: Triamcinolone


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells

object_name: atopic eczema


subject: UMLS:C4722065

subject_name: Substance with prostacyclin receptor agonist mechanism of action (substance)

object_name: pulmonary hypertension, primary, 1


subject: UMLS:C4722065

object_name: pulmonary hypertension


subject: UMLS:C4722065

object_name: idiopathic pulmonary arterial hypertension


subject: UMLS:C4722065

object_name: pulmonary arterial hypertension


subject: UMLS:C4084259

subject_name: Prostacyclin Receptor Agonist [EPC]


subject: UMLS:C4084259


subject: UMLS:C4084259


subject: UMLS:C4084259


subject: UMLS:C1541456

object_name: Advanced cancer


subject: CHEBI:90227

subject_name: Selumetinib


subject: PUBCHEM.COMPOUND:135742497

subject_name: MEK inhibitor


subject: UMLS:C2347168

subject_name: Mitogen-Activated Protein Kinase Kinase Inhibitor


subject: CHEBI:28115

subject_name: Mecobalamin

object_name: amyotrophic lateral sclerosis


subject: CHEBI:17439

subject_name: Cyanocobalamin


subject: UMLS:C5201181

subject_name: H.P. acthar gel

object_name: SLE glomerulonephritis syndrome, WHO class V


subject: CHEBI:7465

subject_name: Naltrexone

object_name: Gambling


subject: CHEBI:16302

object_name: OPTN-related open angle glaucoma


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: UNII:1D1822L42I

subject_name: Polystyrene sulfonate

object_name: Hyperkalemia, CTCAE


subject: UNII:1D1822L42I

object_name: Hyperkalemia


subject: UNII:1D1822L42I

object_name: chronic kidney disease


subject: UNII:1D1822L42I

object_name: Chronic uremia


subject: CHEBI:53280

subject_name: poly(sodium 4-styrenesulfonate)


subject: CHEBI:53280


subject: CHEBI:53280


subject: CHEBI:53280


subject: CHEBI:53279

subject_name: sodium polystyrene sulfonate


subject: CHEBI:53279


subject: CHEBI:53279


subject: CHEBI:53279


subject: UMLS:C0796480

subject_name: Monoclonal Antibody HeFi-1

object_name: adult lymphoma


subject: UMLS:C0796480

object_name: lymphoma


subject: UMLS:C0796480

object_name: pediatric lymphoma


subject: UMLS:C0003405

subject_name: Antiparkinson Agents

object_name: Dysphagia


subject: UMLS:C0003405

object_name: Dysphagia, CTCAE


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Intrusive memories


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Autoimmunity


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: Pemphigoid


subject: CHEBI:231683

subject_name: Anakinra

object_name: osteoarthritis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:80755

object_name: Stomach cancer


subject: CHEBI:80755

object_name: gastric cancer


subject: CHEBI:80755

object_name: carcinoma of esophagus


subject: CHEBI:80755

object_name: esophageal cancer


subject: CHEBI:80755

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:80755

object_name: neoplasm of esophagus


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: nicotine dependence


subject: CHEBI:6933

subject_name: Midodrine

object_name: Shock


subject: CHEBI:134677

subject_name: Crisaborole

object_name: localized scleroderma


subject: CHEBI:134677

object_name: Morphea


subject: DRUGBANK:DB05615

object_name: Raynaud disease


subject: CHEMBL.COMPOUND:CHEMBL2107913

subject_name: OPEBACAN

object_name: graft versus host disease


subject: CHEBI:8378

subject_name: Prednisolone

object_name: familial lipoprotein lipase deficiency


subject: UNII:20OK4AFR4Y

subject_name: Alipogene tiparvovec


subject: UMLS:C1518041

subject_name: Luteinizing Hormone-releasing Hormone Agonist

object_name: pelvic pain on the left


subject: UMLS:C1518041

object_name: pelvic pain occurs with urination


subject: UMLS:C1518041

object_name: pelvic pain occurs with bowel movement


subject: UMLS:C1518041

object_name: pelvic pain decreasing in severity


subject: UMLS:C1518041

object_name: Pelvic pain female


subject: UMLS:C1518041

object_name: pelvic pain increasing in severity


subject: UMLS:C1518041

object_name: male pelvic pain


subject: UMLS:C1518041

object_name: pelvic pain to the rear


subject: UMLS:C1518041

object_name: pelvic pain on the right


subject: UMLS:C1518041

object_name: pelvic pain decreasing in frequency


subject: UMLS:C1518041

object_name: Pelvic pain


subject: UMLS:C1518041

object_name: Pelvic Pain, CTCAE 5.0


subject: UMLS:C1518041

object_name: pelvic pain causes awakening at night


subject: UMLS:C1518041

object_name: pelvic pain increasing in frequency


subject: UMLS:C1518041

object_name: pelvic pain occurs with intercourse


subject: UMLS:C1518041

object_name: pelvic pain in front


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: epidermolysis bullosa


subject: MESH:D000086663

subject_name: COVID-19 Vaccines

object_name: immunodeficiency disease


subject: UMLS:C5400806

subject_name: COVID-19 VACCINE


subject: UMLS:C5438042

subject_name: Agomelatine 25 mg oral tablet

object_name: Depressed mood


subject: UMLS:C1135762

object_name: hypertension


subject: UMLS:C1135762

object_name: Hypertension, CTCAE


subject: UNII:H6MSM69SSM

object_name: panic disorder


subject: UNII:H6MSM69SSM

object_name: panic disorder 1


subject: UNII:55L20667O4


subject: UNII:55L20667O4


subject: CHEBI:48923

subject_name: erythromycin

object_name: Parkinson disease


subject: CHEBI:42355

subject_name: Erythromycin


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:91368

object_name: Metastatic Renal Cell Cancer


subject: PUBCHEM.COMPOUND:58641927

subject_name: Ulixertinib

object_name: digestive system cancer


subject: PUBCHEM.COMPOUND:58641927

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:58641927

object_name: Solid Neoplasm


subject: UMLS:C4287812

subject_name: ulixertinib


subject: UMLS:C4287812


subject: UMLS:C4287812


subject: UMLS:C4287812


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:90227

object_name: Pancreatic carcinoma stage III


subject: CHEBI:90227

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:119915

subject_name: Fentanyl

object_name: mean arterial pressure


subject: CHEBI:119915

object_name: Mean blood pressure


subject: CHEBI:119915

object_name: 3-lead electrocardiogram rhythm strip: heart rate


subject: UNII:PUY08529FK

subject_name: Eleclazine

object_name: long QT syndrome


subject: UNII:PUY08529FK

object_name: familial long QT syndrome


subject: UNII:PUY08529FK

object_name: Prolonged QT interval


subject: CHEBI:17026

subject_name: Progesterone

object_name: arteriosclerosis disorder


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: gastroparesis


subject: CHEBI:8228

object_name: Gastroparesis, CTCAE


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: carcinoma of esophagus


subject: UNII:9G6U5L461Q


subject: UNII:4MD2J2T8SJ

subject_name: brexucabtagene autoleucel

object_name: mantle cell lymphoma


subject: UNII:D07V79Q44T

object_name: Childhood Soft Tissue Sarcoma


subject: UNII:D07V79Q44T

object_name: Adult Soft Tissue Sarcoma


subject: UNII:D07V79Q44T

object_name: sarcoma


subject: UNII:D07V79Q44T

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UNII:D07V79Q44T

object_name: soft tissue sarcoma


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:85990


subject: CHEBI:70839

subject_name: Dasatinib

object_name: systemic mastocytosis


subject: CHEBI:190514


subject: CHEBI:49375


subject: UMLS:C1831724

subject_name: P501-AS15 vaccine

object_name: prostate neoplasm


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin

object_name: respiratory tract infectious disorder


subject: PUBCHEM.COMPOUND:3467

object_name: tracheobronchitis


subject: CHEBI:34574

object_name: atrial fibrillation


subject: CHEBI:42085

subject_name: 7,8-Diamino-Nonanoic Acid


subject: CHEBI:16026

subject_name: 2,6-Diaminopimelic Acid


subject: CHEBI:2247

subject_name: 7,8-diaminononanoic acid


subject: CHEBI:64312

subject_name: Memantine

object_name: fragile X syndrome


subject: CHEBI:47657

subject_name: Roflumilast


subject: CHEBI:177517

subject_name: Bifeprunox

object_name: bipolar I disorder


subject: CHEBI:234112

subject_name: Cenobamate

object_name: Partial Seizure


subject: UMLS:C3653501

subject_name: DIRECT ACTING ANTIVIRALS

object_name: liver cirrhosis


subject: UMLS:C3653501

object_name: hepatitis C virus, susceptibility to


subject: UMLS:C3653501

object_name: liver carcinoma


subject: UMLS:C3653501

object_name: Adverse drug response


subject: UMLS:C3653501

object_name: Drug action (disorder)


subject: UMLS:C4725022

subject_name: PKC-beta Inhibitor MS-553

object_name: lymphoid leukemia


subject: CHEBI:131166

subject_name: Berzosertib

object_name: head and neck squamous cell carcinoma


subject: CHEBI:131166

object_name: Head and Neck Carcinoma of Unknown Primary


subject: CHEBI:131166

object_name: Stage IV Sinonasal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:131166

object_name: Stage IV Laryngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:131166

object_name: Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:131166

object_name: Stage III Sinonasal Squamous Cell Carcinoma AJCC v6 and v7


subject: CHEBI:131166

object_name: Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:131166

object_name: Squamous cell carcinoma of the oral cavity stage IV


subject: CHEBI:131166

object_name: Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7


subject: CHEBI:131166

object_name: Oropharyngeal squamous cell carcinoma stage III


subject: CHEBI:131166

object_name: Squamous cell carcinoma of the oral cavity stage III


subject: CHEBI:131166

object_name: Hypopharyngeal squamous cell carcinoma stage III


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: UNII:T9FVH03HMZ

subject_name: Calaspargase pegol

object_name: Refractory Acute Leukemia of Ambiguous Lineage


subject: UNII:T9FVH03HMZ

object_name: Refractory Acute Lymphoblastic Leukemia


subject: UNII:T9FVH03HMZ

object_name: Refractory Mixed Phenotype Acute Leukemia


subject: UNII:T9FVH03HMZ

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged


subject: UNII:T9FVH03HMZ

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from B Acute Lymphoblastic Leukemia, KMT2A-Rearranged


subject: UNII:T9FVH03HMZ

object_name: Recurrent Acute Leukemia of Ambiguous Lineage


subject: UNII:T9FVH03HMZ

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage


subject: UNII:T9FVH03HMZ

object_name: Refractory Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia


subject: UNII:T9FVH03HMZ

object_name: Acute lymphoblastic leukemia recurrent


subject: UNII:T9FVH03HMZ

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from Acute Leukemia of Ambiguous Lineage


subject: UNII:T9FVH03HMZ

object_name: Recurrent Mixed Phenotype Acute Leukemia


subject: UNII:T9FVH03HMZ

object_name: Recurrent Acute Myeloid Leukemia due to Lineage Switch from Mixed Phenotype Acute Leukemia


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:17650


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382


subject: CHEBI:8382